Albemarle (ALB) Tops Q4 EPS by 13c, Offers FY Guidance
Get Alerts ALB Hot Sheet
Price: $134.51 +1.00%
Financial Fact:
Research and development expenses: 21.01M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Financial Fact:
Research and development expenses: 21.01M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Join SI Premium – FREE
Albemarle (NYSE: ALB) reported Q4 EPS of $1.34, $0.13 better than the analyst estimate of $1.21. Revenue for the quarter came in at $857.8 million versus the consensus estimate of $795.54 million.
GUIDANCE:
Albemarle sees FY2018 EPS of $5.00-$5.40, versus the consensus of $5.14. Albemarle sees FY2018 revenue of $3.2-3.4 billion, versus the consensus of $3.24 billion.
For earnings history and earnings-related data on Albemarle (ALB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Phibro Animal Health (PAHC) Tops Q4 EPS by 13c; Offers Guidance
- Kohl's (KSS) Tops Q2 EPS by 71c; raises guidance
- Ooma (OOMA) Tops Q2 EPS by 2c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share